Stories tagged 'Aude Chapuis'
Good News at Fred Hutch
Celebrating faculty and staff achievements
Dec. 14, 2017
Fred Hutchinson Cancer Research Center has announced awards totaling $1 million to nine of its scientists through the Evergreen Fund, a unique grant program that supports homegrown research projects deemed attractive to potential commercial partners. This is the second year of Evergreen Fund awards. This is the second year of Evergreen Fund awards. The Hutch’s Business Development & Strategy office created the program in 2016 in an effort to encourage scientists to pursue creative ideas with commercial appeal. The goal is to speed research from the bench to the bedside while generating income from patent rights and partnerships with the business sector.
Tags: Aude Chapuis, Bernstein Lab, Business Development & Strategy, Cancer etiology - prevention - outcomes, Clinical Research, D. Gary Gilliland, Damian Green, David MacPherson, gene therapy, genetically engineered t cells, h pylori, hematopoietic stem cell transplant, hicor, Human Biology, Hutch Data Commonwealth, hutchinson institute for cancer outcomes research, Jarrod Dudakov, Jennifer Adair, Multiple Myeloma, Nina Salama, postdoctoral fellow, Scott Ramsey, small cell lung cancer, Taran Gujral, Transplant and Immunotherapy, Tumor specific translational research
Science without borders
At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases
Oct. 16, 2017 | By Mary Engel / Fred Hutch Research Center
Fred Hutch, like other major U.S. cancer research centers, attracts top scientists from around the world working to cure cancer, HIV and other diseases
Tags: Aude Chapuis, Basic Sciences, blood cancer, bone marrow transplantation, brain development, Cameron Turtle, cancer, Cancer etiology - prevention - outcomes, cancer research, Chu Chen, Clinical Research, developmental biology, diversity, Hans-Peter Kiem, Harmit Malik, head neck cancers, hiv, Hutch United, immigrants, immunotherapy, immunotherapy research, international collaboration, Jihong Bai, Jonathan Bricker, Marie Bleakley, Mazyar Shadman, Michael Boeckh, Molecular basis of cancer , neurology, Paul Edlefsen, postdoctoral fellow, Public Health Sciences, Rainer Storb, Stanley R Riddell, Tobacco & Health Behavior Science Research Group, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viral cancers
Triple therapy for rare skin cancer shows promise in small, early-stage trial
Combo of T-cell therapy, newly FDA-approved drug and another immune booster kept cancer at bay for three of four patients with metastatic Merkel cell carcinoma
May 31, 2017 | By Rachel Tompa / Fred Hutch News Service
In a small, ongoing clinical trial testing a combination of three therapies, three of four patients with advanced Merkel cell carcinoma went into complete remission.
(RSS feeds are best viewed in browsers other than Chrome)
Editor's Picks
Immune booster may awaken body's defenses against skin cancer
Persistent HIV infection works a lot like cancer, study shows
Squelching ovarian cancer: the not-so-silent killer
GIVE NOW &
SAVE LIVES
Story Archive
2019
-
- Jan
- Feb
- March
- April
- May
- June
- July
- Aug
- Sept
- Oct
- Nov
- Dec
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
Publications
Magazine Archive
Back issues of Hutch Magazine
Financial Reporting
Fiscal highlights & Annual Reports
Science Spotlight
Monthly review of Center-authored papers
Fred Hutch News
Get updates via email.
